跳至主要内容
临床试验/CTRI/2024/12/078223
CTRI/2024/12/078223尚未招募2/3 期

A Clinical Study To Evaluate The Efficacy Of Chandrasakaladi Vatak And Kandwadau Lepa Churna In The Management Of Dadru

DrYashmine Khan1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年12月27日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
To assess the effect of Chandrasakaladi Vatak in the management of symptomatology of dadru.

研究概览

简要总结

This is a clinical study to assess the efficacy Of Chandrasakaladi Vatak and Kandwadau lepa churna in the management of symptomatology of dadru ( superficial fungal infection) and observe for its reoccurence . This study is done as a mandatory Post graduation thesis work .Total number of patients will be 90 to be studied for 8 weeks.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.The Patients with classical symptoms of dadru ( raga,kandu, pidika,unnata mandala) 2.Patients of either sex 16 years to 70 years 3.Diagnosed cases of Tinea.corporis, Tinea.cruris, Tinea.
  • fasceie, Tinea.barbae as symptoms closely relate to dadru.
  • Direct microscopy (10%KOH) skin test positive.
  • 5.Patients having mild to moderate distribution of leison, size of mandala five to ten centimeter , number of mandala four to six ,pidika less than ten.
  • 6.Patients willing to participate in the study and sign the consent form.

排除标准

  • 1.Pregnant / lactating women
  • Tinea associated with other skin disorders to be excluded .
  • Extensive widespread cases will be excluded.
  • Patients suffering from systemic disorders like uncontrolled diabetes, hypertension, on steroid therapy , immunocompromised condition ,autoimmune disorders which interfere with the course of treatment will be excluded.
  • 5.Cases of Tinea mannum , Tinea Pedia, Tinea.
  • Unguim , Tinea capitis will be excluded .
  • Patients exhibiting hypersensitivity reaction to the trial drug .

结局指标

主要结局

To assess the effect of Chandrasakaladi Vatak in the management of symptomatology of dadru.

时间窗: Day 7, day 14, day 21 ,day 28

To also assess the efficacy Of kandwadau lepa churna in the management of symptomatology of dadru .

时间窗: Day 7, day 14, day 21 ,day 28

To assess combined efficacy of Chandrasakaladi Vatak and Kandwadau lepa churna in the management of symptomatology of dadru.

时间窗: Day 7, day 14, day 21 ,day 28

次要结局

  • To assess for the reoccurence of symptoms of dadru .(At end of 8 week)

研究者

发起方
DrYashmine Khan
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Yashmine khan

Govt. Ayurvedic College and Hospital Ghy -14

研究点 (1)

Loading locations...

相似试验